CBT as an Adjunct to SRIs in the Treatment of BDD

Stopped early · Phase 4

Conditions studied: Body Dysmorphic Disorder

In brief

The research project is a controlled pilot study of the efficacy of cognitive-behavioral therapy (CBT) as an adjunct to serotonin reuptake inhibitor (SRI) pharmacotherapy in body dysmorphic disorder (BDD). This study assesses the efficacy of CBT in comparison to relaxation and stress management training (RSMT), an active control treatment

Key facts

Study ID
NCT00211809
Run by
Icahn School of Medicine at Mount Sinai
People needed
17
Starts
2008-09-01
Expected to finish
2009-06-01
Last updated by the study team
2017-03-09

Who can join

Age: 16 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.